Human Breast Tissue Bioavailability of Topically Applied Limonene
1 other identifier
interventional
103
1 country
1
Brief Summary
The overall objective of this project is to determine the safety and breast tissue bioavailability of limonene following massage application of limonene containing massage oil to the breast.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 breast-cancer
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 20, 2011
CompletedFirst Posted
Study publicly available on registry
October 25, 2011
CompletedApril 21, 2016
October 1, 2011
2.3 years
October 20, 2011
April 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
breast tissue bioavailability
limonene levels in nipple aspirate fluid after 4 weeks of intervention
4 weeks
Secondary Outcomes (1)
safety
6 weeks
Study Arms (1)
Limonene intervention
EXPERIMENTALInterventions
daily massage application to the breast for 4 weeks
Eligibility Criteria
You may qualify if:
- Women who are 18-65 years of age
- ECOG performance status 0-1
- Normal organ and marrow function
- Women of child-bearing potential must agree to use adequate contraception
- Willing to avoid consumption and use of citrus or citrus containing products throughout the study
- Have both breasts intact
You may not qualify if:
- Have had cancer(s) within the past 5 years
- Participated in another clinical interventional trial within the past 3 months
- Uncontrolled intercurrent illness
- Pregnant or breast feeding
- Unable to produce nipple aspirate fluid
- Have known allergic or sensitive reactions to skin care products, citrus or coconut oil
- Have ongoing skin disorders such as eczema and psoriasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Arizonalead
- United States Department of Defensecollaborator
Study Sites (1)
The University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sherry Chow, Ph.D.
The University of Arizona
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2011
First Posted
October 25, 2011
Study Start
October 1, 2007
Primary Completion
February 1, 2010
Study Completion
March 1, 2010
Last Updated
April 21, 2016
Record last verified: 2011-10